Further, the fact that dual HCRT antagonists frequently produce headache (although not migraine or CH-like pain) as a side effect [97, 98] have provided indirect evidence that hypofunction of HCRT signaling may destabilize trigeminal nociceptive processing resulting in headache. The gene discussed is HCRT; the disease is Headache.